ALLIANCE PHARMA PLC

Remuneration Information • May 27, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3812O

Alliance Pharma PLC

27 May 2015

For immediate release	27 May 2015

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Share Options

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that on 27th May 2015 it awarded the following options over ordinary shares of the Company to certain Directors.

Name	Position	Number of Share Options Awarded	Exercise price per Share	Date of vesting	Percentage of issued ordinary share capital
Anthony Booley	Executive Director	146,003	43.75	May 2018	0.055
Peter Butterfield	Executive Director	155,000	43.75	May 2018	0.059

For further information:

### Alliance Pharma plc	### + 44 (0) 1249 466966
John Dawson, Chief Executive
Sarah Robinson, Company Secretary
www.alliancepharma.co.uk
### Buchanan	### + 44 (0) 20 7466 5000
Mark Court / Sophie Cowles / Jane Glover
Numis Securities Limited	+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Freddie Barnfield
Corporate Broking: David Poutney

Notes to editors:

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSPKODPBBKDKPB